Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the PFS of patients with advanced or metastatic NSCLC, when treated with TAS-114/S-1 combination versus S-1 in patients with advanced solid tumor for which no standard therapy exists
Critère d'inclusion
- Male and female patients age 18 years or older with histologically or cytologically confirmed advanced or metastatic NSCLC for whom standard therapy no longer exists